Literature DB >> 28756907

Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver disease.

Greta Westwood1, Paul Meredith2, Susan Atkins2, Peter Greengross3, Paul E Schmidt2, Richard J Aspinall4.   

Abstract

BACKGROUND & AIMS: Many people who die from alcohol related liver disease (ARLD) have a history of recurrent admissions to hospital, representing potential missed opportunities for intervention. Universal screening for alcohol misuse has been advocated but it is not known if this is achievable or effective at detecting individuals at high risk of ARLD.
METHODS: We systematically screened all admissions to the Acute Medical Unit (AMU) of a large acute hospital using an electronic data capture system in real time. Patients at an increasing risk of alcohol harm were referred for either brief intervention (BI) or further assessment by an Alcohol Specialist Nursing Service (ASNS). Additional data were recorded on admission diagnoses, alcohol unit consumption, previous attendances, previous admissions, length of stay and mortality.
RESULTS: Between July 2011 and March 2014, there were 53,165 admissions and 48,211 (90.68%) completed screening. Of these, 1,122 (2.3%) were classified as "increasing", and 1,921 (4.0%) as "high" risk of alcohol harm. High risk patients had more hospital admissions in the three previous years (average 4.74) than the low (3.00) and increasing (2.92) risk groups (p<0.001). The high risk patients also had more frequent emergency department (ED) attendances (7.68) than the lower (2.64) and increasing (3.81) groups (p<0.001 for both). A total of 1,396 (72.6%) of the high risk group were seen by the ASNS and 1,135 (81.2%) had an Alcohol Use Disorders Identification Test (AUDIT) score over 20 with 527 (37.8%) recording the maximum value of 40. Compared to the other groups, high risk patients had a distinct profile of admissions with the most common diagnoses being mental health disorders, gastro-intestinal bleeding, poisoning and liver disease.
CONCLUSIONS: Universal screening of admissions for alcohol misuse is feasible and identifies a cohort with frequent ED attendances, recurrent admissions and an elevated risk of ARLD. An additional group of patients at an increasing risk of alcohol harm can be identified in a range of common presentations. These patients can be targeted with interventions to reduce the burden of alcohol related harm. Lay summary: Many people who die from alcohol related liver disease (ARLD) have a recent history of recurrent admissions to hospital. These admissions may represent missed opportunities to intervene earlier and offer effective therapies for alcohol misuse. Unfortunately, we know that patients are often missed because medical staff may not routinely ask about alcohol consumption. In our study of over 50,000 admissions, we have demonstrated the feasibility of offering screening for alcohol misuse to all medical admissions to hospital and delivered this 24hours a day, 7days a week, with automatic referral to treatment services. We have shown that it is possible to identify those people who are at the highest risk of dependency, those who have attended the emergency department the most and those who are at an increased risk of ARLD. We hope this study will lead to improved detection and management of alcohol problems in acute hospitals.
Copyright © 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol; Alcohol related liver disease; Cirrhosis; Dependency; Screening

Mesh:

Year:  2017        PMID: 28756907     DOI: 10.1016/j.jhep.2017.04.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  10 in total

1.  Current Management and Future Treatment of Alcoholic Hepatitis.

Authors:  Mack C Mitchell; Thomas Kerr; H Franklin Herlong
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-04

Review 2.  Outpatient management of alcohol-related liver disease.

Authors:  Douglas A Simonetto; Vijay H Shah; Patrick S Kamath
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-05

3.  Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide.

Authors:  Neil D Shah; Meritxell Ventura-Cots; Juan G Abraldes; Mohamed Alboraie; Ahmad Alfadhli; Josepmaria Argemi; Ester Badia-Aranda; Enrique Arús-Soler; A Sidney Barritt; Fernando Bessone; Marina Biryukova; Flair J Carrilho; Marlen Castellanos Fernández; Zaily Dorta Guiridi; Mohamed El Kassas; Teo Eng-Kiong; Alberto Queiroz Farias; Jacob George; Wenfang Gui; Prem H Thurairajah; John Chen Hsiang; Azra Husić-Selimovic; Vasily Isakov; Mercy Karoney; Won Kim; Johannes Kluwe; Rakesh Kochhar; Narendra Dhaka; Pedro Marques Costa; Mariana A Nabeshima Pharm; Suzane K Ono; Daniela Reis; Agustina Rodil; Caridad Ruenes Domech; Federico Sáez-Royuela; Christoph Scheurich; Way Siow; Nadja Sivac-Burina; Edna Solange Dos Santos Traquino; Fatma Some; Sanjin Spreckic; Shiyun Tan; Julio Vorobioff; Andrew Wandera; Pengbo Wu; Mohamed Yacoub; Ling Yang; Yuanjie Yu; Nerma Zahiragic; Chaoqun Zhang; Helena Cortez-Pinto; Ramon Bataller
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-29       Impact factor: 11.382

4.  Outcomes of excessive alcohol drinkers without baseline evidence of chronic liver disease after 15 years follow-up: Heavy burden of cancer and liver disease mortality.

Authors:  Sónia Bernardo; Ricardo Crespo; Sofia Saraiva; Rui Barata; Sara Gonçalves; Paulo Nogueira; Helena Cortez-Pinto; Mariana Verdelho Machado
Journal:  PLoS One       Date:  2021-05-25       Impact factor: 3.240

5.  Critical Role of General Practitioners in Preventing Readmission Following Emergency Department Alcohol Screening and Brief Intervention Management of Alcohol-Related Problems.

Authors:  Simon Hazeldine; Imogen Davies; Robert J Tait; John K Olynyk
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

6.  Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals.

Authors:  V V Pavan Kedar Mukthinuthalapati; Samuel Akinyeye; Zachary P Fricker; Moinuddin Syed; Eric S Orman; Lauren Nephew; Eduardo Vilar-Gomez; James Slaven; Naga Chalasani; Maya Balakrishnan; Michelle T Long; Bashar M Attar; Marwan Ghabril
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

7.  Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis.

Authors:  Hamish Innes; Alex J Walker; Jennifer Benselin; Jane I Grove; Vincent Pedergnana; M Azim Ansari; Shang-Kuan Lin; John McLauchlan; Sharon J Hutchinson; Eleanor Barnes; William L Irving; Indra Neil Guha
Journal:  Clin Transl Gastroenterol       Date:  2022-02-09       Impact factor: 4.396

8.  The influence of electronic reminders on recording diagnoses in a primary health care emergency department: a register-based study in a Finnish town.

Authors:  Mika Lehto; Kaisu Pitkälä; Ossi Rahkonen; Merja K Laine; Marko Raina; Timo Kauppila
Journal:  Scand J Prim Health Care       Date:  2021-04-14       Impact factor: 2.581

Review 9.  Reducing the Global Burden of Alcohol-Associated Liver Disease: A Blueprint for Action.

Authors:  Sumeet K Asrani; Jessica Mellinger; Juan P Arab; Vijay H Shah
Journal:  Hepatology       Date:  2021-05       Impact factor: 17.298

10.  Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders.

Authors:  Archita P Desai; Marion Greene; Lauren D Nephew; Eric S Orman; Marwan Ghabril; Naga Chalasani; Nir Menachemi
Journal:  Clin Transl Gastroenterol       Date:  2021-06-18       Impact factor: 4.488

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.